CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,827,352 | +331.7% | 1,340,300 | +395.3% | 0.03% | +285.7% |
| Q3 2022 | $1,813,000 | -84.0% | 270,600 | -69.7% | 0.01% | -87.3% |
| Q4 2020 | $11,297,000 | +48.4% | 893,741 | +15.3% | 0.06% | +41.0% |
| Q3 2020 | $7,611,000 | +315.4% | 775,000 | +320.9% | 0.04% | +225.0% |
| Q2 2020 | $1,832,000 | +117.3% | 184,138 | +222.3% | 0.01% | +200.0% |
| Q3 2017 | $843,000 | -79.9% | 57,134 | -86.2% | 0.00% | -86.2% |
| Q3 2016 | $4,190,000 | -7.7% | 414,479 | +2.5% | 0.03% | -6.5% |
| Q2 2016 | $4,542,000 | -5.1% | 404,479 | +15.4% | 0.03% | -16.2% |
| Q1 2016 | $4,786,000 | -42.1% | 350,372 | -36.9% | 0.04% | -35.1% |
| Q2 2015 | $8,264,000 | +3.9% | 555,000 | +5.7% | 0.06% | +5.6% |
| Q1 2015 | $7,954,000 | +19.4% | 525,200 | +5.0% | 0.05% | +14.9% |
| Q4 2014 | $6,660,000 | -1.1% | 500,000 | -6.4% | 0.05% | -7.8% |
| Q3 2014 | $6,736,000 | – | 534,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |